Warning: in_array() expects parameter 2 to be array, null given in /home/pharmalicensing/public_html/detail.php on line 234

Warning: in_array() expects parameter 2 to be array, null given in /home/pharmalicensing/public_html/inc_stats.php on line 82

Warning: array_push() expects parameter 1 to be array, null given in /home/pharmalicensing/public_html/inc_stats.php on line 85
Pharmalicensing | Life Science's Global Technology Marketplace
Save this technology
close
Save to Existing Project
Save to a New Project
Esmolol 2500 Mg/10ml Ampoule
Orpha Swiss GmbH Switzerland flag Switzerland
Abstract ID:
Ultrashort acting beta blocker Esmolol for use in anesthesia, intensive care, cardiology and internal medicine....
Contact
Participants
You
Email me a copy of this message
MECHANISM OF ACTION
Beta blocker, selective blockade of beta 1 receptors

Esmolol is an ultra fast acting beta1-receptor blocker (cardio selective) with a very short elimination half-life of 9 minutes. This product is used for the short-term treatment of supraventricular tachycardia and for the rapid control of ventricular rate in patients with atrial fibrillation or atrial flutter in perioperative, postoperative, or other circumstances where short-term control of the ventricular rate with a short acting agent is desirable (e.g. myocardial infarct). Target groups are anaesthetists and ICU-clinicians. Generic verion.

GO PREMIUM TO GET PATENT INFORMATION
Type of Business Relationship Sought

Country specific or regional distribution contract.

FEATURED
Last Updated Oct 2014
Technology Type THERAPEUTIC
Phase of Development REGISTERED / FDA APPROVED / FINISHED PRODUCT
CORPORATION
Company Logo